Key Highlights:
- Elevance Health (ELV, Financial) maintains a steady dividend with a forward yield of 1.64%.
- Wall Street analysts predict a potential 19.47% upside based on average price targets.
- GuruFocus values ELV with an approximate 49.62% upside potential.
Elevance Health (NYSE: ELV) remains committed to rewarding its shareholders, having declared a stable quarterly dividend of $1.71 per share, which translates to a forward yield of 1.64%. Investors looking to benefit from this dividend should ensure their shares are recorded by June 10, with distribution set for June 25. Additionally, Elevance Health has reiterated its 2025 earnings per share (EPS) expectations, projecting a range between $34.15 and $34.85, underlining its strategic growth initiatives, particularly in the Carelon sector.
Analyst Price Predictions
An analysis of 19 Wall Street professionals reveals a diverse outlook for Elevance Health Inc's (ELV, Financial) stock value over the next year. The average target price is positioned at $496.87, with projections peaking at $585.00 and a lower boundary of $428.00. This average price indicates a potential upside of 19.47% from its current market position of $415.90. For further exploration of these estimates, visit the Elevance Health Inc (ELV) Forecast page.
Brokerage Recommendations
Elevance Health Inc (ELV, Financial) enjoys an "Outperform" rating based on consensus data from 24 brokerage firms, which yields an average recommendation score of 2.0. It's essential to note that this rating scale ranges from 1 to 5, where 1 indicates a Strong Buy and 5 suggests a Sell. This reinforces the stock's favorable standing among financial analysts.
GuruFocus Valuation
According to GuruFocus estimates, the one-year GF Value for Elevance Health Inc (ELV, Financial) is projected at $622.26. This estimate points to a potential upside of 49.62% from its current trading price of $415.90. The GF Value metric represents GuruFocus’ calculated fair value, derived from historical trading multiples, business growth history, and future performance forecasts. Investors seeking more comprehensive analysis should refer to the Elevance Health Inc (ELV) Summary page.
Also check out: (Free Trial)
